Umb Bank, N.A. Iovance Biotherapeutics, Inc. Transaction History
Umb Bank, N.A.
- $6.22 Billion
- Q4 2024
Shares
1 transactions
Others Institutions Holding IOVA
# of Institutions
341Shares Held
248MCall Options Held
4.04MPut Options Held
3.1M-
Vanguard Group Inc Valley Forge, PA27.5MShares$153 Million0.0% of portfolio
-
Mhr Fund Management LLC New York, NY24.4MShares$136 Million24.02% of portfolio
-
Perceptive Advisors LLC New York, NY22.1MShares$123 Million5.46% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$118 Million0.0% of portfolio
-
State Street Corp Boston, MA12.2MShares$68.2 Million0.0% of portfolio
About IOVANCE BIOTHERAPEUTICS, INC.
- Ticker IOVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 157,800,992
- Market Cap $879M
- Description
- Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...